Serum inhibin A and activin A are elevated prior to the onset of pre-eclampsia

Human Reproduction

Volumn 15, Issue 7, 2000, Pages 1640-1645

  Muttukrishna, S ^a,d   North, R A ^b   Morris, J ^a   Schellenberg, J C ^b   Taylor, R S ^b   Asselin, J ^a   Ledger, W ^a   Groome, N ^c   Redman, C W G ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b NATIONAL WOMEN S HOSPITAL   (New Zealand)

^c OXFORD BROOKES UNIVERSITY   (United Kingdom)

^d JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

Activin A; Gestational hypertension; Inhibin A; Pre eclampsia; Pregnancy

Indexed keywords

ACTIVIN A; INHIBIN A;

ADULT; ARTICLE; CLINICAL TRIAL; CONCENTRATION RESPONSE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; FEMALE; GESTATION PERIOD; HUMAN; MAJOR CLINICAL STUDY; PREDICTION; PREECLAMPSIA; PRENATAL SCREENING; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL;

EID: 0033797919     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/15.7.1640     Document Type: Article

References (35)

1. Second trimester maternal serum inhibin A concentrations as an early marker for pre-eclampsia
2. The value of elevated second-trimester beta-human chorionic gonadotropin in predicting development of pre-eclampsia
3. Inhibin A and activin A in the first trimester of human pregnancy
4. Activin is a local regulator of human cytotrophoblast cell differentiation
5. Low-dose aspirin to prevent pre-eclampsia in women at high risk. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units
6. Maternal serum inhibin A can predict pre-eclampsia
7. Evaluating diagnostic tests
8. Partial characterization of inhibin, activin, and follistatin in the term human placenta
9. Inhibin-A and pro-alpha C are elevated in preeclamptic pregnancy and correlate with human chorionic gonadotropin
10. Detection of dimeric inhibin throughout the human menstrual cycle by two-site enzyme immunoassay
11. Regulation of activin A production by amnion, decidua, and placenta in vitro by proinflammatory cytokine
12. Inhibin A and activin A levels in the second trimester as predictors of pre-eclampsia
13. Development and application of a two-site enzyme immunoassay for the determination of 'total' activin-A concentrations in serum and follicular fluid
14. The human placenta: A novel source of inhibin
15. Measurement of serum concentrations of inhibin-A (alpha-beta A dimer) during human pregnancy
16. Changes in peripheral serum levels of total activin A during the human menstrual cycle and pregnancy
17. Source of circulating levels of inhibin A, pro alpha C-containing inhibins and activin A in early pregnancy
18. Activin A and inhibin A as possible endocrine markers for pre-eclampsia
19. Heterogeneous causes constituting the single syndrome of pre-eclampsia: A hypothesis and its implications
20. Uterine artery Doppler flow velocity waveforms in the second trimester for the prediction of pre-eclampsia and fetal growth retardation
21. Serum activin A and follistatin concentrations during human pregnancy: A cross-sectional and longitudinal study
22. Corticotrophin-releasing hormone and corticotrophin-releasing hormone binding protein in normal and pre-eclamptic human pregnancies
23. Inhibin, activin and follistatin in the human placenta - A new family of regulatory proteins
24. Hypertension in pregnancy: Changes in activin A maternal serum concentration
25. Inhibin and activin production in human placenta
26. Current topic, pre-eclampsia and the placenta
27. Management of pre-eclampsia
28. Pre-eclampsia, an excessive maternal inflammatory response to pregnancy
29. Pre-eclampsia, more than pregnancy-induced hypertension
30. Secretory component of immunoglobulin A in maternal serum and the prediction of preterm delivery
31. A protocol for managing severe pre-eclampsia in the second trimester
32. Activin-A stimulates, while transforming growth factor beta 1 inhibits, chorionic gonadotrophin production and aromatase activity in cultured human placental trophoblasts
33. Urinary calcium in asymptomatic primigravidas who later developed pre-eclampsia
34. Placental mitochondria as a source of oxidative stress in pre-eclampsia
35. Induced expression of the new cytokine, activin A, in human monocytes: Inhibition by glucocorticoids and retinoic acid